Old Web
English
Sign In
Acemap
>
authorDetail
>
Jerry W. Snidow
Jerry W. Snidow
GlaxoSmithKline
Medicine
Virology
Protease
Abacavir
Diabetes mellitus
3
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor
2013
American Journal of Obstetrics and Gynecology
Jerry W. Snidow
Hugh Miller
Guillermo J. Valenzuela
Steve Thornton
Brendt Stier
Linda M. Clayton
Mike Fossler
Tim Montague
Kathleen J. Beach
Pauline Williams
Show All
Source
Cite
Save
Citations (7)
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
2005
BMC Infectious Diseases
Philip Keiser
Michael Sension
Edwin DeJesus
Allan E Rodriguez
Jeffrey F. Olliffe
Vanessa C. Williams
John H. Wakeford
Jerry W. Snidow
Anne Shachoy-Clark
Julie W. Fleming
Gary E. Pakes
Jaime E. Hernandez
Show All
Source
Cite
Save
Citations (38)
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
2005
BMC Infectious Diseases
Susan Swindells
Calvin Cohen
Daniel Berger
Karen T. Tashima
Qiming Liao
Bonnie Pobiner
Jerry W. Snidow
Gary E. Pakes
Jaime E. Hernandez
Show All
Source
Cite
Save
Citations (8)
1